Ziggy, here is what we know, but not everyone accepts these facts:
1) The officers and directors know the data, i.e., they can't buy shares during this "quiet period" (length unknown);
2) The EMA has seen a glimpse of the data and asked Anavex to file;
3) Rett results were 3x better than approved competitors' results and will be discussed with agencies, including fda; and,
4) New information on brain volume loss that shows Anavex's blarcamesine is less damaging, if at all, than the mabs' impact and this information might be added to filings in progress.
I believe Tred, Pazzo and ignatius have replied to directly and/or indirectly to some of the bashers over the weekend. The true situation at Anavex can't not be heard amongst all the cacophony around it.
We will know in time ... length unknown.
Bullish
Market Data 
Markets 
